Crenolanib besylate (CP-868596-26; 4-piperidinamine 1-[2-[5-[(3-Methyl-3-oxetanyl) methoxy]-1H-benzimidazol-1-yl]- 8-quinolinyl]- monobenzenesulfonate) is an investigational inhibitor being developed by AROG Pharmaceuticals LLC.
This page contains content from the copyrighted Wikipedia article "Crenolanib"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
